J. Lauring, A. M. Abukhdeir, H. Konishi, J. P. Garay, J. P. Gustin et al., The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity, Blood, vol.111, issue.2, pp.856-64, 2008.
DOI : 10.1182/blood-2007-05-088674

P. L. Bergsagel and W. M. , Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma, Journal of Clinical Oncology, vol.23, issue.26, pp.6333-6341, 2005.
DOI : 10.1200/JCO.2005.05.021

J. J. Keats, T. Reiman, C. A. Maxwell, B. J. Taylor, L. M. Larratt et al., In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression, Blood, vol.101, issue.4, pp.1520-1529, 2003.
DOI : 10.1182/blood-2002-06-1675

J. J. Keats, C. A. Maxwell, B. J. Taylor, M. J. Hendzel, M. Chesi et al., Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients, Blood, vol.105, issue.10, pp.4060-4069, 2005.
DOI : 10.1182/blood-2004-09-3704

M. Santra, F. Zhan, E. Tian, B. Barlogie, J. Shaughnessy et al., A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript, Blood, vol.101, issue.6, pp.2374-2380, 2003.
DOI : 10.1182/blood-2002-09-2801

C. B. Yoo and P. A. Jones, Epigenetic therapy of cancer: past, present and future, Nature Reviews Drug Discovery, vol.316, issue.1, pp.37-50, 2006.
DOI : 10.1038/nrd1930

J. Marango, M. Shimoyama, H. Nishio, J. A. Meyer, D. J. Min et al., The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor, Blood, vol.111, issue.6, pp.3145-54, 2008.
DOI : 10.1182/blood-2007-06-092122

J. Y. Kim, H. J. Kee, N. W. Choe, S. M. Kim, G. H. Eom et al., Multiple Myeloma-Related WHSC1/MMSET Isoform RE-IIBP Is a Histone Methyltransferase with Transcriptional Repression Activity, Molecular and Cellular Biology, vol.28, issue.6, pp.2023-2057, 2008.
DOI : 10.1128/MCB.02130-07

J. Li, C. Yin, H. Okamoto, H. Mushlin, B. M. Balgley et al., Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas, Neuro-Oncology, vol.10, issue.1, pp.45-51, 2008.
DOI : 10.1215/15228517-2007-036

D. R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally et al., ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform, Neoplasia, vol.6, issue.1, pp.1-6, 2004.
DOI : 10.1016/S1476-5586(04)80047-2

URL : http://doi.org/10.1016/s1476-5586(04)80047-2

L. Sun, A. M. Hui, Q. Su, A. Vortmeyer, Y. Kotliarov et al., Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain, Cancer Cell, vol.9, issue.4, pp.287-300, 2006.
DOI : 10.1016/j.ccr.2006.03.003

P. J. French, S. M. Swagemakers, J. H. Nagel, M. C. Kouwenhoven, E. Brouwer et al., Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas, Cancer Research, vol.65, issue.24, pp.11335-11379, 2005.
DOI : 10.1158/0008-5472.CAN-05-1886

R. Shai, T. Shi, T. J. Kremen, S. Horvath, L. M. Liau et al., Gene expression profiling identifies molecular subtypes of gliomas, Oncogene, vol.22, issue.31, pp.4918-4941, 2003.
DOI : 10.1038/sj.onc.1206753

X. Chen, S. T. Cheung, S. So, S. T. Fan, C. Barry et al., Gene Expression Patterns in Human Liver Cancers, Molecular Biology of the Cell, vol.13, issue.6, pp.1929-1968, 2002.
DOI : 10.1091/mbc.02-02-0023

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117615/pdf

E. Wurmbach, Y. B. Chen, G. Khitrov, W. Zhang, S. Roayaie et al., Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma, Hepatology, vol.28, issue.4, pp.938-985, 2007.
DOI : 10.1002/hep.21622

A. Cromer, A. Carles, R. Millon, G. Ganguli, F. Chalmel et al., Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis, Oncogene, vol.23, issue.14, pp.2484-98, 2004.
DOI : 10.1038/sj.onc.1207345

D. Pyeon, M. A. Newton, P. F. Lambert, J. A. Den-boon, S. Sengupta et al., Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus-Positive and Human Papillomavirus-Negative Head/Neck and Cervical Cancers, Cancer Research, vol.67, issue.10, pp.4605-4624, 2007.
DOI : 10.1158/0008-5472.CAN-06-3619

M. Sanchez-carbayo, N. D. Socci, J. Lozano, and F. , Defining Molecular Profiles of Poor Outcome in Patients With Invasive Bladder Cancer Using Oligonucleotide Microarrays, Journal of Clinical Oncology, vol.24, issue.5, pp.778-89, 2006.
DOI : 10.1200/JCO.2005.03.2375

L. Dyrskjot, M. Kruhoffer, T. Thykjaer, N. Marcussen, J. L. Jensen et al., Gene Expression in the Urinary Bladder: A Common Carcinoma in Situ Gene Expression Signature Exists Disregarding Histopathological Classification, Cancer Research, vol.64, issue.11, pp.4040-4048, 2004.
DOI : 10.1158/0008-5472.CAN-03-3620

D. H. Ki, H. C. Jeung, C. H. Park, S. H. Kang, G. Y. Lee et al., Whole genome analysis for liver metastasis gene signatures in colorectal cancer, International Journal of Cancer, vol.418, issue.9, pp.2005-2017, 2007.
DOI : 10.1002/ijc.22975

E. T. Kimchi, M. C. Posner, J. O. Park, T. E. Darga, M. Kocherginsky et al., Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation, Cancer Res, vol.65, pp.3146-54, 2005.

A. L. Richardson, Z. C. Wang, A. De-nicolo, X. Lu, M. Brown et al., X chromosomal abnormalities in basal-like human breast cancer, Cancer Cell, vol.9, issue.2, pp.121-153, 2006.
DOI : 10.1016/j.ccr.2006.01.013

T. Johansson and . Fioretos, Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status, Leukemia, vol.21, pp.1198-203, 2007.

B. E. Wong, T. R. Johnson, D. J. Golub, M. Sugarbaker, and . Meyerson, Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses, Proc Natl Acad Sci, pp.98-13790, 2001.

S. Wachi, K. Yoneda, and R. Wu, Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues, Bioinformatics, vol.21, issue.23, pp.4205-4213, 2005.
DOI : 10.1093/bioinformatics/bti688

L. J. Su, C. W. Chang, Y. C. Wu, K. C. Chen, C. J. Lin et al., Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap resampling scheme, BMC Genomics, vol.8, issue.140, 2007.

K. Basso, A. A. Margolin, G. Stolovitzky, U. Klein, R. Dalla-favera et al., Reverse engineering of regulatory networks in human B cells, Nature Genetics, vol.14, issue.4, pp.382-90, 2005.
DOI : 10.1101/gad.906601

K. S. Hoek, N. C. Schlegel, P. Brafford, A. Sucker, S. Ugurel et al., Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature, Pigment Cell Research, vol.11, issue.4, pp.290-302, 2006.
DOI : 10.1016/S0960-9822(01)00360-8

D. Talantov, A. Mazumder, J. X. Yu, T. Briggs, Y. Jiang et al., Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions, Clinical Cancer Research, vol.11, issue.20, pp.7234-7276, 2005.
DOI : 10.1158/1078-0432.CCR-05-0683

C. Haqq, M. Nosrati, D. Sudilovsky, J. Crothers, D. Khodabakhsh et al., The gene expression signatures of melanoma progression, Proceedings of the National Academy of Sciences, vol.102, issue.17, pp.6092-6099, 2005.
DOI : 10.1073/pnas.0501564102

F. Zhan, B. Barlogie, V. Arzoumanian, Y. Huang, D. R. Williams et al., Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis, Blood, vol.109, issue.4, pp.1692-700, 2007.
DOI : 10.1182/blood-2006-07-037077

J. Lapointe, C. Li, J. P. Higgins, M. Van-de-rijn, E. Bair et al., Gene expression profiling identifies clinically relevant subtypes of prostate cancer, Proceedings of the National Academy of Sciences, vol.101, issue.3, pp.811-817, 2004.
DOI : 10.1073/pnas.0304146101

S. Nanni, C. Priolo, A. Grasselli, M. D. Eletto, R. Merola et al., Epithelial-Restricted Gene Profile of Primary Cultures from Human Prostate Tumors: A Molecular Approach to Predict Clinical Behavior of Prostate Cancer, Molecular Cancer Research, vol.4, issue.2, pp.79-92, 2006.
DOI : 10.1158/1541-7786.MCR-05-0098

S. M. Dhanasekaran, A. Dash, J. Yu, I. P. Maine, B. Laxman et al., Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty, The FASEB Journal, vol.19, pp.243-248, 2005.
DOI : 10.1096/fj.04-2415fje

D. K. Vanaja, J. C. Cheville, S. J. Iturria, and C. Y. Young, Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression, Cancer Res, vol.63, pp.3877-82, 2003.

S. A. Tomlins, R. Mehra, D. R. Rhodes, X. Cao, L. Wang et al., Integrative molecular concept modeling of prostate cancer progression, Nature Genetics, vol.100, issue.1, pp.41-51, 2007.
DOI : 10.1038/ng1935

Y. P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren et al., Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy, Journal of Clinical Oncology, vol.22, issue.14, pp.2790-2799, 2004.
DOI : 10.1200/JCO.2004.05.158

P. Liu, S. Ramachandran, M. A. Seyed, C. D. Scharer, N. Laycock et al., Sex-Determining Region Y Box 4 Is a Transforming Oncogene in Human Prostate Cancer Cells, Cancer Research, vol.66, issue.8, pp.4011-4020, 2006.
DOI : 10.1158/0008-5472.CAN-05-3055

R. I. Skotheim, G. E. Lind, O. Monni, J. M. Nesland, V. M. Abeler et al., Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development, Cancer Research, vol.65, issue.13, pp.5588-98, 2005.
DOI : 10.1158/0008-5472.CAN-05-0153

N. D. Hendrix, R. Wu, R. Kuick, D. R. Schwartz, E. R. Fearon et al., Fibroblast Growth Factor 9 Has Oncogenic Activity and Is a Downstream Target of Wnt Signaling in Ovarian Endometrioid Adenocarcinomas, Cancer Research, vol.66, issue.3, pp.1354-62, 2006.
DOI : 10.1158/0008-5472.CAN-05-3694

K. H. Lu, A. P. Patterson, L. Wang, R. T. Marquez, E. N. Atkinson et al., Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis, Clinical Cancer Research, vol.10, issue.10, pp.3291-300, 2004.
DOI : 10.1158/1078-0432.CCR-03-0409

M. L. Gumz, H. Zou, P. A. Kreinest, A. C. Childs, L. S. Belmonte et al., Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma, Clinical Cancer Research, vol.13, issue.16, pp.4740-4749, 2007.
DOI : 10.1158/1078-0432.CCR-07-0143

D. Lindgren, F. Liedberg, A. Andersson, G. Chebil, S. Gudjonsson et al., Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q, Oncogene, vol.30, issue.18, pp.2685-96, 2006.
DOI : 10.1038/sj.onc.1209249

Y. Asselain, C. C. Allory, D. G. Abbou, J. P. Albertson, D. K. Thiery et al., Regional copy number-independent deregulation of transcription in cancer, Nat Genet, vol.38, pp.1386-96, 2006.

L. Dyrskjot, K. Zieger, M. Kruhoffer, T. Thykjaer, J. L. Jensen et al., A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome, Clinical Cancer Research, vol.11, issue.11, pp.4029-4065, 2005.
DOI : 10.1158/1078-0432.CCR-04-2095

A. V. Ivshina, J. George, O. Senko, B. Mow, T. C. Putti et al., Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer, Cancer Research, vol.66, issue.21, pp.10292-301, 2006.
DOI : 10.1158/0008-5472.CAN-05-4414

L. D. Miller, J. Smeds, J. George, V. B. Vega, L. Vergara et al., From The Cover: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, Proceedings of the National Academy of Sciences, vol.102, issue.38, pp.13550-13555, 2005.
DOI : 10.1073/pnas.0506230102

C. Ginestier, N. Cervera, P. Finetti, S. Esteyries, B. Esterni et al., Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers, Clinical Cancer Research, vol.12, issue.15, pp.4533-4577, 2006.
DOI : 10.1158/1078-0432.CCR-05-2339

URL : https://hal.archives-ouvertes.fr/hal-01431971

H. Zhao, A. Langerod, Y. Ji, K. W. Nowels, J. M. Nesland et al., Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast, Molecular Biology of the Cell, vol.15, issue.6, pp.2523-2559, 2004.
DOI : 10.1091/mbc.E03-11-0786

G. V. Glinsky, A. B. Glinskii, A. J. Stephenson, R. M. Hoffman, and W. L. Gerald, Gene expression profiling predicts clinical outcome of prostate cancer, Journal of Clinical Investigation, vol.113, issue.6, pp.913-936, 2004.
DOI : 10.1172/JCI20032DS1

B. Bachtiary, P. C. Boutros, M. Pintilie, W. Shi, C. Bastianutto et al., Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity, Clinical Cancer Research, vol.12, issue.19, pp.5632-5672, 2006.
DOI : 10.1158/1078-0432.CCR-06-0357

X. J. Yang, M. H. Tan, H. L. Kim, J. A. Ditlev, M. W. Betten et al., A Molecular Classification of Papillary Renal Cell Carcinoma, Cancer Research, vol.65, issue.13, pp.5628-5665, 2005.
DOI : 10.1158/0008-5472.CAN-05-0533

C. H. Chung, J. S. Parker, G. Karaca, J. Wu, W. K. Funkhouser et al., Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression, Cancer Cell, vol.5, issue.5, pp.489-500, 2004.
DOI : 10.1016/S1535-6108(04)00112-6

R. A. Brennan and . Depinho, High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients, Cancer Cell, vol.9, pp.313-338, 2006.

W. A. Freije, F. E. Castro-vargas, Z. Fang, S. Horvath, T. Cloughesy et al., Gene Expression Profiling of Gliomas Strongly Predicts Survival, Cancer Research, vol.64, issue.18, pp.6503-6513, 2004.
DOI : 10.1158/0008-5472.CAN-04-0452